2025 Cutaneous Squamous Cell Carcinoma (CSCC) Market Insights: Analyzing Size, Share & Growth Potential

29 Apr, 2025

The Cutaneous Squamous Cell Carcinoma (CSCC) Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.

What are the Historical Growth Trends in the Cutaneous Squamous Cell Carcinoma (CSCC) Market?

The market size for cutaneous squamous cell carcinoma (cSCC) has expanded notably in the past few years. The market is forecasted to increase from $7.45 billion in 2024 to $7.90 billion in 2025, with a compound annual growth rate (CAGR) of 6.1%.

What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Cutaneous Squamous Cell Carcinoma (CSCC) Industry?

The global market for Cutaneous Squamous Cell Carcinoma (cSCC) is projected to reach $9.90 billion by 2029, growing at a compound annual growth rate (CAGR) of 5.8%.

Download Your Free Sample of the 2025 Cutaneous Squamous Cell Carcinoma (CSCC) Market Report and Uncover Key Trends Now!

What are the Key Growth Drivers Fueling the Cutaneous Squamous Cell Carcinoma (CSCC) Market?

The key drivers in the cutaneous squamous cell carcinoma (cscc) market are:

• Increasing availability of targeted therapies
• Higher awareness of skin cancer prevention
• Expansion of medical tourism for cancer treatments
• Increasing adoption of minimally invasive surgeries

Global Market Segmentation: Identifying Major Cutaneous Squamous Cell Carcinoma (CSCC) Industry Segments

The cutaneous squamous cell carcinoma (CSCC) market covered in this report is segmented –
1) By Treatment: Surgical Treatment, Non-Surgical Treatment
2) By Diagnosis: Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Biopsy
3) By Application: Hospitals, Cancer Institutes, Ambulatory Surgical Centers, Other Applications Subsegments:
1) By Surgical Treatment: Excisional Surgery, Mohs Micrographic Surgery, Curettage And Electrodessication
2) By Non-Surgical Treatment: Radiation Therapy, Cryotherapy, Photodynamic Therapy, Topical Therapies, Systemic Therapies

Pre-order the 2025 Cutaneous Squamous Cell Carcinoma (CSCC) Global Market Report for Fast Delivery & Comprehensive Insights!

What are the emerging Trends Shaping the Future of the Cutaneous Squamous Cell Carcinoma (CSCC) Market?

The key trends in the cutaneous squamous cell carcinoma (cscc) market are:

• The advancements in dermatology diagnostics are impacting the CSCC market greatly.
• The development of advanced radiotherapy techniques is a trending innovation.
• The future of the CSCC market is influenced by the increasing technological integration in dermatology.
• There are growing developments in immunotherapy treatments and photodynamic therapy.

Who Are the Top Competitors & Leading Players in the Cutaneous Squamous Cell Carcinoma (CSCC) Market?

Major players in the cutaneous squamous cell carcinoma (cscc) market are:

• F. Hoffmann-La Roche AG
• Merck & Co. Inc.
• Sanofi S.A.
• Bristol-Myers Squibb Company
• Novartis AG
• GSK plc
• 3M Company
• Eli Lilly and Company
• Amgen Inc.
• Boehringer Ingelheim
• Regeneron Pharmaceuticals Inc.
• Astellas Pharma Inc.
• Incyte Corporation
• Hikma Pharmaceuticals plc
• Shanghai Henlius Biotech Inc.
• Fortress Biotech Inc.
• Rakuten Medical Inc.
• Morphogenesis Inc.
• CureVac N.V.
• Vidac Pharma Inc.

Regional Dominance: Which Area Leads the Global Template Market?

North America was the largest region in the cutaneous squamous cell carcinoma (CSCC) market in 2024